← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2011Last known activity
Feb 28, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (13 distinct, 3 trials)
Phase 3 (11 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (4)
- NCT05724745Lead sponsorN/AFeb 28, 2023
- NCT05724745Reponsible party - principal investigatorN/AFeb 28, 2023
- NCT03784014CollaboratorPhase 3Mar 31, 2019
- NCT01377220Lead sponsorPhase 2Jun 1, 2011
Details
- Last known activity
- Feb 28, 2023